Quick answers
- What is ZYPREXA Zydis?
- ZYPREXA Zydis is a brand name of Olanzapine, a prescription medicine. The FDA NDC Directory lists 4 ZYPREXA Zydis products in 4 strengths and forms.
- Who makes ZYPREXA Zydis?
- Cheplapharm holds the FDA application for ZYPREXA Zydis (NDA021086, approved April 6, 2000).
- Is there a generic or store brand of ZYPREXA Zydis?
- Yes. The FDA NDC Directory lists 53 other products with the same active ingredients, strength and form as a ZYPREXA Zydis product, 53 of them generic. Ask your pharmacist whether one is right for you.
- Has ZYPREXA Zydis been recalled?
- No recall linked to ZYPREXA Zydis products (by their NDC code or label) appears in the FDA enforcement reports we use.
What ZYPREXA Zydis is
Each ZYPREXA Zydis product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Olanzapine · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| olanzapine 10 mg tablet, orally disintegrating (oral) | ZYPREXA Zydis | 14 products, 14 companies | — |
| olanzapine 15 mg tablet, orally disintegrating (oral) | ZYPREXA Zydis | 13 products, 13 companies | — |
| olanzapine 20 mg tablet, orally disintegrating (oral) | ZYPREXA Zydis | 12 products, 12 companies | — |
| olanzapine 5 mg tablet, orally disintegrating (oral) | ZYPREXA Zydis | 14 products, 14 companies | — |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Olanzapine →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA021086 | Cheplapharm | April 6, 2000 | 4 |
Companies that list ZYPREXA Zydis
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of ZYPREXA Zydis products.
- H2-Pharma LLC4 products
Recalls
No recall linked to ZYPREXA Zydis products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.